Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the clinical performance of the rotating platform and fixed bearing implants in patients undergoing primary total knee replacement. Outcome scoring and radiographic assessment will be the methods used to evaluate performance.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This study will evaluate the clinical performance of rotating platform and fixed bearing knee implants. This will be done by obtaining a series of primary total knee replacements. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Retaining Knee System or the P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System and assignment is randomized.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1 P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System |
Device: Total Knee Replacement
Rotating Platform (RP) Cruciate Retaining Knee System
Other Names:
|
Active Comparator: 2 P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System |
Device: Total knee replacement
Fixed Cruciate Retaining Knee System
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Knee Society Scores [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and < 60 = poor.
Secondary Outcome Measures
- Complications/Revisions [On-going to end of study.]
- Medical Imaging [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
- SF-12 Patient Outcomes [Pre-operative, 6 and 12 months and annually thereafter for at least 5 years.]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Osteoarthritis
-
Rheumatoid Arthritis
-
Other inflammatory arthritis
-
Avascular necrosis of bone
Exclusion Criteria:
-
Prior ipsilateral TKA
-
Metabolic disorders
-
Joint replacement due to autoimmune disorders
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Billings | Montana | United States | 59101 | |
2 | Vancouver | Washington | United States | 98664 |
Sponsors and Collaborators
- DePuy Orthopaedics
Investigators
- Study Director: Tammy L O'Dell, EMT, CCRA, CCRC, DePuy Orthopaedics
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SRP-2
Study Results
Participant Flow
Recruitment Details | Two US clinical centers performed 99 primary knee replacements in 86 subjects. Recruitment was based on the inclusion and exclusion criteria as specified in the clinical investigation plan. |
---|---|
Pre-assignment Detail | Immediately before surgery, the implant type was determined according to the randomization schedule. Before treatment assignment, consented subjects could be excluded from the trial based on results of pre-operative clinical evaluations and/or radiographs, as per the exclusion criteria in the CIP. |
Arm/Group Title | Rotating Platform | Fixed Bearing |
---|---|---|
Arm/Group Description | P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. | P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base. |
Period Title: Overall Study | ||
STARTED | 50 | 49 |
COMPLETED | 3 | 2 |
NOT COMPLETED | 47 | 47 |
Baseline Characteristics
Arm/Group Title | Rotating Platform | Fixed Bearing | Total |
---|---|---|---|
Arm/Group Description | P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. | P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base. | Total of all reporting groups |
Overall Participants | 50 | 49 | 99 |
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
63.7
(6.2)
|
66.9
(5.1)
|
65.3
(5.9)
|
Sex: Female, Male (Count of Participants) | |||
Female |
31
62%
|
26
53.1%
|
57
57.6%
|
Male |
19
38%
|
23
46.9%
|
42
42.4%
|
Region of Enrollment (participants) [Number] | |||
United States |
50
100%
|
49
100%
|
99
100%
|
Outcome Measures
Title | Knee Society Scores |
---|---|
Description | The Knee Society Score (KSS) is comprised to two sections (each worth 100 points) for a maximum 200 points. One section is the Knee Society Clinical Score (KSCS) - points are given for pain, motion, and stability and points are deducted for flexion contracture, extension lag, and misalignment. The other section is the Knee Society Functional Score (KSFS) - points are assigned for walking distances and climbing stairs and points are deducted for use of walking aids. For each section, a score of 80-100 = excellent, 70-79 = good; 60-69 = fair; and < 60 = poor. |
Time Frame | Pre-operative, 6 and 12 months and annually thereafter for at least 5 years. |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Rotating Platform | Fixed Bearing |
---|---|---|
Arm/Group Description | P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. | P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base. |
Measure Participants | 50 | 49 |
Pre-operative |
40.8
(19.8)
|
43.4
(23.0)
|
6 months |
84.3
(14.7)
|
77.8
(14.9)
|
12 months |
86.4
(13.0)
|
86.4
(10.0)
|
24 months |
89.7
(9.2)
|
88.1
(8.8)
|
36 months |
92.3
(8.2)
|
87.1
(10.4)
|
48 months |
94.3
(5.6)
|
86.0
(14.7)
|
60 months |
95.0
(4.6)
|
95.5
(3.5)
|
Title | Complications/Revisions |
---|---|
Description | |
Time Frame | On-going to end of study. |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | Medical Imaging |
---|---|
Description | |
Time Frame | Pre-operative, 6 and 12 months and annually thereafter for at least 5 years. |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Title | SF-12 Patient Outcomes |
---|---|
Description | |
Time Frame | Pre-operative, 6 and 12 months and annually thereafter for at least 5 years. |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title |
---|
Arm/Group Description |
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Rotating Platform | Fixed Bearing | ||
Arm/Group Description | P.F.C.® Sigma™ Rotating Platform (RP) Cruciate Retaining Knee System has a modular polyethylene insert that is free to rotate around a central pivot point during knee motion. | P.F.C.® Sigma™ Fixed Cruciate Retaining Knee System implant has a modular polyethylene insert that is intraoperatively locked into position on the metal tibial base. | ||
All Cause Mortality |
||||
Rotating Platform | Fixed Bearing | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Rotating Platform | Fixed Bearing | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 3/50 (6%) | 1/49 (2%) | ||
Cardiac disorders | ||||
Cardiacvascular arrhythmia | 2/50 (4%) | 2 | 0/49 (0%) | 0 |
General disorders | ||||
Death | 1/50 (2%) | 1 | 0/49 (0%) | 0 |
Musculoskeletal and connective tissue disorders | ||||
Femoral Fracture | 0/50 (0%) | 0 | 1/49 (2%) | 1 |
Other (Not Including Serious) Adverse Events |
||||
Rotating Platform | Fixed Bearing | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/50 (0%) | 0/49 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
Results Point of Contact
Name/Title | Tammy O'Dell, EMT, CCRA |
---|---|
Organization | DePuy Orthopaedics, Inc. |
Phone | 574-372-7104 |
TOdell2@its.jnj.com |
- SRP-2